美股市场个股详情
JAZZ 爵士制药
- 113.180
- +1.270+1.13%
收盘价 10/30 16:00 (美东)
- 112.000
- -1.180-1.04%
盘后 19:15 (美东)
69.89亿总市值19.18市盈率TTM
113.580最高价110.655最低价33.62万股成交量110.840今开111.910昨收3794.33万成交额0.56%换手率18.55市盈率(静)6175.35万总股本134.48052周最高1.86市净率67.87亿流通值99.06052周最低--股息TTM5996.59万流通股194.730历史最高--股息率TTM2.61%振幅0.515历史最低112.868平均价1股每手
关于爵士制药公司
Jazz Pharmaceuticals是一家位于爱尔兰的生物制药公司，主要专注于睡眠障碍和肿瘤的治疗。Jazz在神经科学和肿瘤适应症领域有9种获批药物;其产品组合包括治疗嗜睡症的Xyrem和Xywav，治疗转移性小细胞肺癌的Zepzelca，治疗急性淋巴细胞白血病的Rylaze，以及治疗急性髓细胞白血病的Vyxeos。2021年5月，Jazz收购了GW Pharmaceuticals，获得了其主要产品Epidiolex，用于治疗严重、罕见类型的癫痫。
公司介绍
公司代码JAZZ
公司名称爵士制药
上市日期2007/06/01
发行价格18.00
成立日期2005
CEOMr. Bruce C. Cozadd
所属市场纳斯达克
员工数量2800
年结日12-31
公司地址Waterloo Exchange,Waterloo Road,5th Floor
城市Dublin
省份都柏林
国家爱尔兰共和国
邮编4
电话353-1-634-7800
董事高管
- 姓名
- 职务
- 年薪
- Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 1534.12万
- Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 387.74万
- Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
- Renee D. Gala
- President and Chief Operating Officer
- 543.44万
- Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 140.10万
- Samantha Pearce
- Senior Vice President, Europe and International
- --
- Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 497.91万
- Liz Henderson
- Senior Vice President, Technical Operations
- --
- Patrick Thomas Kennedy
- Independent Director
- --
- Dr. Norbert G. Riedel,PhD
- Independent Director
- 53.38万
- Kenneth W. O'Keefe
- Independent Director
- 51.38万
- Anne O'Riordan
- Independent Director
- 52.38万
- Laura J. Hamill
- Independent Director
- --
- Heather Ann McSharry
- Independent Director
- 54.38万
- Jennifer E. Cook
- Independent Director
- 53.38万
- Seamus C. Mulligan
- Independent Director
- 53.13万
- Dr. Mark D. Smith, M.D.
- Independent Director
- 52.13万
- Patrick G. Enright
- Independent Director
- 52.63万
- Rick E. Winningham
- Lead Independent Director
- 57.13万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据